HealthWell Foundation — Head and Neck Cancer Fund

Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.

Maximum award Up to $6,500 · Income ≤500% FPL · Covers drug cost only — administration billed separately

CLOSED
Status verified June 11, 2026 · Source: HealthWell Foundation fund page ↗
Fund is currently closed. Monitor for reopening.

Fund facts

Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.

Assistance type
Copay Grant
Maximum award
Up to $6,500
What it covers
Covers drug cost only — administration billed separately
Income limit
≤500% FPL
Insurance
commercial medicare no medicaid
Diagnosis required
Head and Neck Cancer (confirmed diagnosis)
Residency
US resident
ICD-10
C00 C01 C02 C02.0 C02.1 C02.2 C02.3 C02.4 C03 C04 C05 C06 C07 C08 C09 C09.0 C09.1 C10 C10.0 C10.2 C10.3 C11 C12 C13 C13.0 C13.1 C13.2 C14 C30 C31 C32 C32.0 C32.1 C32.2 C32.3 C80.0 C80.1
Processing time
5–10 business days
Renewal
annual reapplication
Fund availability depends on donations. May close and reopen periodically.

Covered drugs in our billing library

Drugs whose J-codes this fund matches. Each links to its billing & coding reference.

Also matches J-codes not yet in our drug library: J9023 J9055

Published formulary

The foundation's own covered-medication list for this fund (145 drugs). Confirm coverage of your exact NDC at application.

Show all 145 covered medications
  • Abiraterone Acetate
  • Abitrexate
  • Abraxane
  • Absorica
  • Accutane
  • Ado-trastuzumab Emtansine
  • Adriamycin
  • Adrucil
  • Afatinib
  • Alimta
  • Aminolevulinic Acid
  • Amnesteem
  • Augtyro
  • Avelumab
  • Axitinib
  • Balversa
  • Bavencio
  • Bicalutamide
  • Blenoxane
  • Bleomycin
  • Camcevi
  • Capecitabine
  • Carboplatin
  • Casodex
  • Cetuximab
  • Cisplatin
  • Claravis
  • Cyclophosphamide
  • Dabrafenib Mesylate
  • Docetaxel
  • Docivyx
  • Doxorubicin Hydrochloride
  • Efudex
  • Eligard
  • Eloxatin
  • Enhertu
  • Entrectinib
  • Erbitux
  • Erdafitinib
  • Etopophos
  • Etoposide
  • Etoposide Phosphate
  • Fam-trastuzumab Deruxtecan-nxki
  • Fluoroplex
  • Fluorouracil
  • Folex
  • Folex Pfs
  • Gemcitabine
  • Gemzar
  • Gilotrif
  • Gleolan
  • Goserelin Acetate
  • Herceptin
  • Hercessi
  • Herzuma
  • Hydrea
  • Hydroxyurea
  • Ifex
  • Ifosfamide
  • Inlyta
  • Ipilimumab
  • Isotretinoin
  • Jylamvo
  • Kadcyla
  • Kanjinti
  • Kemoplat
  • Keytruda
  • Keytruda Qlex
  • Larotrectinib
  • Lenvatinib
  • Lenvima
  • Leucovorin Calcium
  • Leuprolide Acetate
  • Loqtorzi
  • Lupron Depot
  • Mekinist
  • Methotrexate
  • Methotrexate Lpf
  • Mexate
  • Mexate-aq
  • Mitomycin
  • Mitoxantrone Hydrochloride
  • Mutamycin
  • Myorisan
  • Navelbine
  • Nexavar
  • Nivolumab
  • Nivolumab And Hyaluronidase-nvhy
  • Ogivri
  • Ontruzant
  • Onxol
  • Opdivo
  • Opdivo Qvantig
  • Oxaliplatin
  • Paclitaxel
  • Paclitaxel, Protein-bound
  • Paraplatin
  • Pembrolizumab
  • Pembrolizumab And Berahyaluronidase Alfa-pmph
  • Pemetrexed
  • Pemfexy
  • Pemrydi Rtu
  • Perjeta
  • Pertuzumab
  • Platinol
  • Platinol-aq
  • Prednisone
  • Rayos
  • Repotrectinib
  • Retevmo
  • Rheumatrex
  • Rozlytrek
  • Selpercatinib
  • Sorafenib Tosylate
  • Tafinlar
  • Taxol
  • Taxotere
  • Temodar
  • Temozolomide
  • Tevimbra
  • Tislelizumab-jsgr
  • Toposar
  • Toripalimab-tpzi
  • Trametinib
  • Trastuzumab-anns
  • Trastuzumab-dkst
  • Trastuzumab-dttb
  • Trastuzumab-pkrb
  • Trastuzumab-qyyp
  • Trastuzumab-strf
  • Trastuzumab
  • Trazimera
  • Trelstar
  • Trexall
  • Triptodur
  • Triptorelin Pamoate
  • Vincristine Sulfate
  • Vinorelbine
  • Vitrakvi
  • Xatmep
  • Xeloda
  • Yervoy
  • Zenatane
  • Zoladex
  • Zytiga

This fund is closed — here's the move

Fund status changes with donations, often without an announcement — confirm directly with the foundation at 800-675-8416, and check the alternatives below.

Manufacturer copay programs may also apply — see the drug pages: Tecentriq, Avastin / biosimilars, Imfinzi, Yervoy.

Other funds covering these drugs

Status shown as of each fund's last verification.

Common questions

Is the HealthWell Foundation Head and Neck Cancer fund open?

As of June 11, 2026, the HealthWell Foundation Head and Neck Cancer fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 800-675-8416.

How much assistance does the Head and Neck Cancer fund provide?

Up to $6,500. Covers drug cost only — administration billed separately

What are the income limits for the Head and Neck Cancer fund?

Household income must be ≤500% FPL. US resident.

What insurance does the Head and Neck Cancer fund accept?

Accepted: commercial, medicare. Not eligible: medicaid.

How long does the Head and Neck Cancer fund take to process an application?

The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.

Patient or caregiver? Show this page to your infusion center's financial counselor — they can check what you'd qualify for and apply on your behalf, or call HealthWell Foundation at 800-675-8416.